Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma

Published:2017-11-06 Issue:63 Volume:8 Page:107096-107108
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kissel Maria¹,Berndt Sandra²,Fiebig Lukas¹,Kling Simon³,Ji Qunsheng⁴,Gu Qingyang⁴,Lang Tina⁵,Hafner Frank-Thorsten¹,Teufel Michael⁶,Zopf Dieter²

Affiliation:

1. Drug Discovery, Bayer AG, Wuppertal, Germany

2. Drug Discovery, Bayer AG, Berlin, Germany

3. Biochemistry, NMI Natural and Medicinal Sciences Institute, University of Tübingen, Reutlingen, Germany

4. Research Service Division, Oncology & Immunology Unit, WuXi AppTec Co. Ltd., Shanghai, China

5. Research & Clinical Sciences Statistics, Bayer AG, Berlin, Germany

6. Translational Medicine Oncology, Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine;Life;2024-09-10

2. Small-molecule-based targeted therapy in liver cancer;Molecular Therapy;2024-08

3. Intratumoral heterogeneity after targeted therapy in murine cancer models with differing degrees of malignancy;Translational Oncology;2023-11

4. Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesis;British Journal of Cancer;2023-08-24

5. Vascular response patterns to targeted therapies in murine breast cancer models with divergent degrees of malignancy;Breast Cancer Research;2023-05-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3